Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1992 Apr;33(4):357–363. doi: 10.1111/j.1365-2125.1992.tb04052.x

The treatment of osteoarthritis.

A C Jones 1, M Doherty 1
PMCID: PMC1381323  PMID: 1576063

Abstract

1. The treatment of osteoarthritis is currently purely symptomatic. To enable rational therapy, careful clinical assessment is necessary to identify the origin of symptoms. Often, effective therapy can result from a biomechanical approach such as surgery, orthotics, physiotherapy and dieting. If drugs are required, there is little evidence that the current over-reliance on non-steroidal anti-inflammatory drugs (NSAIDs) is justified. Full dose regular paracetamol should be the first line of analgesic therapy. In the majority of patients, simple analgesics are probably as effective as NSAIDs. If NSAIDs are used it is necessary to review regularly their use and to be aware of potential toxicity. 2. Many alternative strategies of pain management such as topical preparations, intra-articular steroid injections, acupuncture, radiosynovectomy, transcutaneous nerve stimulation and anti-depressants, may be effective but their precise place in the armamentarium is not yet fully established. 3. The realisation that osteoarthritis is not a passive 'wear and tear' phenomenon but an active process that may be potentially modified, has led to interest in 'chondroprotective' agents, which may beneficially affect the osteoarthritic process. To date there are no convincing data available that such agents are, in fact, chondroprotective in humans.

Full text

PDF
357

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altman R. D. Design and conduct of clinical trials in osteoarthritis. Scand J Rheumatol Suppl. 1990;81:24–27. doi: 10.3109/03009749009096942. [DOI] [PubMed] [Google Scholar]
  2. Altman R. D., Gray R. Inflammation in osteoarthritis. Clin Rheum Dis. 1985 Aug;11(2):353–365. [PubMed] [Google Scholar]
  3. Bagge E., Bjelle A., Edén S., Svanborg A. Osteoarthritis in the elderly: clinical and radiological findings in 79 and 85 year olds. Ann Rheum Dis. 1991 Aug;50(8):535–539. doi: 10.1136/ard.50.8.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Blackshear J. L., Napier J. S., Davidman M., Stillman M. T. Renal complications of nonsteroidal antiinflammatory drugs: identification and monitoring of those at risk. Semin Arthritis Rheum. 1985 Feb;14(3):163–175. doi: 10.1016/0049-0172(85)90035-6. [DOI] [PubMed] [Google Scholar]
  5. Blake D. R., Merry P., Unsworth J., Kidd B. L., Outhwaite J. M., Ballard R., Morris C. J., Gray L., Lunec J. Hypoxic-reperfusion injury in the inflamed human joint. Lancet. 1989 Feb 11;1(8633):289–293. doi: 10.1016/s0140-6736(89)91305-6. [DOI] [PubMed] [Google Scholar]
  6. Bloom B. S. Cost of treating arthritis and NSAID-related gastrointestinal side-effects. Aliment Pharmacol Ther. 1988;2 (Suppl 1):131–138. doi: 10.1111/j.1365-2036.1988.tb00772.x. [DOI] [PubMed] [Google Scholar]
  7. Bradley J. D., Brandt K. D., Katz B. P., Kalasinski L. A., Ryan S. I. Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med. 1991 Jul 11;325(2):87–91. doi: 10.1056/NEJM199107113250203. [DOI] [PubMed] [Google Scholar]
  8. Brooks P. M., Dougan M. A., Mugford S., Meffin E. Comparative effectiveness of 5 analgesics in patients with rheumatoid arthritis and osteoarthritis. J Rheumatol. 1982 Sep-Oct;9(5):723–726. [PubMed] [Google Scholar]
  9. Buckland-Wright J. C., Macfarlane D. G., Lynch J. A., Clark B. Quantitative microfocal radiographic assessment of progression in osteoarthritis of the hand. Arthritis Rheum. 1990 Jan;33(1):57–65. doi: 10.1002/art.1780330107. [DOI] [PubMed] [Google Scholar]
  10. Burkhardt D., Ghosh P. Laboratory evaluation of antiarthritic drugs as potential chondroprotective agents. Semin Arthritis Rheum. 1987 Nov;17(2 Suppl 1):3–34. [PubMed] [Google Scholar]
  11. Carson J. L., Strom B. L., Morse M. L., West S. L., Soper K. A., Stolley P. D., Jones J. K. The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs. Arch Intern Med. 1987 Jun;147(6):1054–1059. [PubMed] [Google Scholar]
  12. Caruso I., Bianchi Porro G. Gastroscopic evaluation of anti-inflammatory agents. Br Med J. 1980 Jan 12;280(6207):75–78. doi: 10.1136/bmj.280.6207.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Chamchan U., Waikakul S., Pukanchana-Mo-Rakote C. Clinical efficacy of glycosaminoglycan polysulfate for the treatment of osteoarthritis of the knee joint: a double blind controlled study. J Med Assoc Thai. 1989 Mar;72(3):123–128. [PubMed] [Google Scholar]
  14. Coles L. S., Fries J. F., Kraines R. G., Roth S. H. From experiment to experience: side effects of nonsteroidal anti-inflammatory drugs. Am J Med. 1983 May;74(5):820–828. doi: 10.1016/0002-9343(83)91073-2. [DOI] [PubMed] [Google Scholar]
  15. Dieppe P. A., Sathapatayavongs B., Jones H. E., Bacon P. A., Ring E. F. Intra-articular steroids in osteoarthritis. Rheumatol Rehabil. 1980 Nov;19(4):212–217. doi: 10.1093/rheumatology/19.4.212. [DOI] [PubMed] [Google Scholar]
  16. Dixon A. S., Jacoby R. K., Berry H., Hamilton E. B. Clinical trial of intra-articular injection of sodium hyaluronate in patients with osteoarthritis of the knee. Curr Med Res Opin. 1988;11(4):205–213. doi: 10.1185/03007998809114237. [DOI] [PubMed] [Google Scholar]
  17. Doherty M. 'Chondroprotection' by non-steroidal anti-inflammatory drugs. Ann Rheum Dis. 1989 Aug;48(8):619–621. doi: 10.1136/ard.48.8.619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Doherty M., Holt M., MacMillan P., Watt I., Dieppe P. A reappraisal of 'analgesic hip'. Ann Rheum Dis. 1986 Apr;45(4):272–276. doi: 10.1136/ard.45.4.272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Doherty M., Watt I., Dieppe P. Influence of primary generalised osteoarthritis on development of secondary osteoarthritis. Lancet. 1983 Jul 2;2(8340):8–11. doi: 10.1016/s0140-6736(83)90003-x. [DOI] [PubMed] [Google Scholar]
  20. Doogan D. P. Topical non-steroidal anti-inflammatory drugs. Lancet. 1989 Nov 25;2(8674):1270–1271. doi: 10.1016/s0140-6736(89)91869-2. [DOI] [PubMed] [Google Scholar]
  21. Doyle D. V., Dieppe P. A., Scott J., Huskisson E. C. An articular index for the assessment of osteoarthritis. Ann Rheum Dis. 1981 Feb;40(1):75–78. doi: 10.1136/ard.40.1.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Felson D. T., Anderson J. J., Naimark A., Kannel W., Meenan R. F. The prevalence of chondrocalcinosis in the elderly and its association with knee osteoarthritis: the Framingham Study. J Rheumatol. 1989 Sep;16(9):1241–1245. [PubMed] [Google Scholar]
  23. Flanagan J., Casale F. F., Thomas T. L., Desai K. B. Intra-articular injection for pain relief in patients awaiting hip replacement. Ann R Coll Surg Engl. 1988 May;70(3):156–157. [PMC free article] [PubMed] [Google Scholar]
  24. Friedman D. M., Moore M. E. The efficacy of intraarticular steroids in osteoarthritis: a double-blind study. J Rheumatol. 1980 Nov-Dec;7(6):850–856. [PubMed] [Google Scholar]
  25. Gammer W., Brobäck L. G. Clinical comparison of orgotein and methylprednisolone acetate in the treatment of osteoarthrosis of the knee joint. Scand J Rheumatol. 1984;13(2):108–112. doi: 10.3109/03009748409100372. [DOI] [PubMed] [Google Scholar]
  26. Gershon S. Chronic pain: hypothesized mechanism and rationale for treatment. Neuropsychobiology. 1986;15 (Suppl 1):22–27. doi: 10.1159/000118275. [DOI] [PubMed] [Google Scholar]
  27. Gibson T., Winter P. J., Grahame R. Radiotherapy in the treatment of osteoarthrosis of the knee. Rheumatol Rehabil. 1973 Feb;12(1):42–46. doi: 10.1093/rheumatology/12.1.42. [DOI] [PubMed] [Google Scholar]
  28. Goldenberg D. L. Fibromyalgia syndrome. An emerging but controversial condition. JAMA. 1987 May 22;257(20):2782–2787. doi: 10.1001/jama.257.20.2782. [DOI] [PubMed] [Google Scholar]
  29. Gramajo R. J., Cutroneo E. J., Fernandez D. E., Gibson J. L., Cáceres Maldonado J. C., Romero F. L., Houssay R. H. A single-blind, placebo-controlled study of glycosaminoglycan-peptide complex ('Rumalon') in patients with osteoarthritis of the hip or knee. Curr Med Res Opin. 1989;11(6):366–373. doi: 10.1185/03007998909110137. [DOI] [PubMed] [Google Scholar]
  30. Gray R. G., Tenenbaum J., Gottlieb N. L. Local corticosteroid injection treatment in rheumatic disorders. Semin Arthritis Rheum. 1981 May;10(4):231–254. doi: 10.1016/0049-0172(81)90001-9. [DOI] [PubMed] [Google Scholar]
  31. Grecomoro G., Martorana U., Di Marco C. Intra-articular treatment with sodium hyaluronate in gonarthrosis: a controlled clinical trial versus placebo. Pharmatherapeutica. 1987;5(2):137–141. [PubMed] [Google Scholar]
  32. Griffin M. R., Piper J. M., Daugherty J. R., Snowden M., Ray W. A. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med. 1991 Feb 15;114(4):257–263. doi: 10.7326/0003-4819-114-4-257. [DOI] [PubMed] [Google Scholar]
  33. Huskisson E. C., Dieppe P. A., Tucker A. K., Cannell L. B. Another look at osteoarthritis. Ann Rheum Dis. 1979 Oct;38(5):423–428. doi: 10.1136/ard.38.5.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Hutton C. W. Generalised osteoarthritis: an evolutionary problem? Lancet. 1987 Jun 27;1(8548):1463–1465. doi: 10.1016/s0140-6736(87)92209-4. [DOI] [PubMed] [Google Scholar]
  35. Kantor T. G. Concepts in pain control. Semin Arthritis Rheum. 1989 May;18(4 Suppl 2):94–99. doi: 10.1016/0049-0172(89)90025-5. [DOI] [PubMed] [Google Scholar]
  36. Keagy R. D., Keim H. A. Intra-articular steroid therapy: repeated use in patients with chronic arthritis. Am J Med Sci. 1967 Jan;253(1):45–51. [PubMed] [Google Scholar]
  37. Kerzberg E. M., Roldán E. J., Castelli G., Huberman E. D. Combination of glycosaminoglycans and acetylsalicylic acid in knee osteoarthrosis. Scand J Rheumatol. 1987;16(5):377–380. doi: 10.3109/03009748709102512. [DOI] [PubMed] [Google Scholar]
  38. Kjaersgaard-Andersen P., Nafei A., Skov O., Madsen F., Andersen H. M., Krøner K., Hvass I., Gjøderum O., Pedersen L., Branebjerg P. E. Codeine plus paracetamol versus paracetamol in longer-term treatment of chronic pain due to osteoarthritis of the hip. A randomised, double-blind, multi-centre study. Pain. 1990 Dec;43(3):309–318. doi: 10.1016/0304-3959(90)90028-C. [DOI] [PubMed] [Google Scholar]
  39. Massardo L., Watt I., Cushnaghan J., Dieppe P. Osteoarthritis of the knee joint: an eight year prospective study. Ann Rheum Dis. 1989 Nov;48(11):893–897. doi: 10.1136/ard.48.11.893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Mayer J. H. Carpometacarpal osteoarthritis of the thumb. Lancet. 1970 Aug 1;2(7666):270–270. doi: 10.1016/s0140-6736(70)92628-0. [DOI] [PubMed] [Google Scholar]
  41. Mazières B., Masquelier A. M., Capron M. H. A French controlled multicenter study of intraarticular orgotein versus intraarticular corticosteroids in the treatment of knee osteoarthritis: a one-year followup. J Rheumatol Suppl. 1991 Feb;27:134–137. [PubMed] [Google Scholar]
  42. McAlindon T., Dieppe P. The medical management of osteoarthritis of the knee: an inflammatory issue? Br J Rheumatol. 1990 Dec;29(6):471–473. doi: 10.1093/rheumatology/29.6.471. [DOI] [PubMed] [Google Scholar]
  43. McIlwain H., Silverfield J. C., Cheatum D. E., Poiley J., Taborn J., Ignaczak T., Multz C. V. Intra-articular orgotein in osteoarthritis of the knee: a placebo-controlled efficacy, safety, and dosage comparison. Am J Med. 1989 Sep;87(3):295–300. doi: 10.1016/s0002-9343(89)80154-8. [DOI] [PubMed] [Google Scholar]
  44. Mejersjo C. Therapeutic and prognostic considerations in TMJ osteoarthrosis: a literature review and a long-term study in 11 subjects. Cranio. 1987 Jan;5(1):69–78. [PubMed] [Google Scholar]
  45. Merritt J. L. Soft tissue mechanisms of pain in osteoarthritis. Semin Arthritis Rheum. 1989 May;18(4 Suppl 2):51–56. doi: 10.1016/0049-0172(89)90016-4. [DOI] [PubMed] [Google Scholar]
  46. Newman N. M., Ling R. S. Acetabular bone destruction related to non-steroidal anti-inflammatory drugs. Lancet. 1985 Jul 6;2(8445):11–14. doi: 10.1016/s0140-6736(85)90058-3. [DOI] [PubMed] [Google Scholar]
  47. Parr G., Darekar B., Fletcher A., Bulpitt C. J. Joint pain and quality of life; results of a randomised trial. Br J Clin Pharmacol. 1989 Feb;27(2):235–242. doi: 10.1111/j.1365-2125.1989.tb05356.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Pastinen O., Forsskåhl B., Marklund M. Local glycosaminoglycan polysulphate injection therapy in osteoarthritis of the hand. A placebo-controlled clinical study. Scand J Rheumatol. 1988;17(3):197–202. doi: 10.3109/03009748809098782. [DOI] [PubMed] [Google Scholar]
  49. Pattrick M., Aldridge S., Hamilton E., Manhire A., Doherty M. A controlled study of hand function in nodal and erosive osteoarthritis. Ann Rheum Dis. 1989 Dec;48(12):978–982. doi: 10.1136/ard.48.12.978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Pelletier J. P., Martel-Pelletier J. Protective effects of corticosteroids on cartilage lesions and osteophyte formation in the Pond-Nuki dog model of osteoarthritis. Arthritis Rheum. 1989 Feb;32(2):181–193. doi: 10.1002/anr.1780320211. [DOI] [PubMed] [Google Scholar]
  51. Pond M. J., Nuki G. Experimentally-induced osteoarthritis in the dog. Ann Rheum Dis. 1973 Jul;32(4):387–388. doi: 10.1136/ard.32.4.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Progression of osteoarthritis and drug treatment. Lancet. 1989 Oct 14;2(8668):914–915. [PubMed] [Google Scholar]
  53. Pybus P. K. Osteo-arthritis of the hip treated by intraneural injection. A simplified technique for the relief of intractable osteo-arthritic pain. Med Hypotheses. 1987 Apr;22(4):357–363. doi: 10.1016/0306-9877(87)90030-2. [DOI] [PubMed] [Google Scholar]
  54. Radin E. L., Burr D. B. Hypothesis: joints can heal. Semin Arthritis Rheum. 1984 Feb;13(3):293–302. doi: 10.1016/0049-0172(84)90031-3. [DOI] [PubMed] [Google Scholar]
  55. Rashad S., Revell P., Hemingway A., Low F., Rainsford K., Walker F. Effect of non-steroidal anti-inflammatory drugs on the course of osteoarthritis. Lancet. 1989 Sep 2;2(8662):519–522. doi: 10.1016/s0140-6736(89)90651-x. [DOI] [PubMed] [Google Scholar]
  56. Rejholec V. Long-term studies of antiosteoarthritic drugs: an assessment. Semin Arthritis Rheum. 1987 Nov;17(2 Suppl 1):35–53. [PubMed] [Google Scholar]
  57. Rønningen H., Langeland N. Indomethacin treatment in osteoarthritis of the hip joint. Does the treatment interfere with the natural course of the disease? Acta Orthop Scand. 1979 Apr;50(2):169–174. doi: 10.3109/17453677908989752. [DOI] [PubMed] [Google Scholar]
  58. Siegmeth W., Radi I. Vergleich von Glykosaminoglykanpolysulfat (Arteparon) und physiologischer Kochsalzlösung bei Arthrosen grosser Gelenke. Ergebnisse einer multizentrischen Doppelblindstudie. Z Rheumatol. 1983 Jul-Aug;42(4):223–228. [PubMed] [Google Scholar]
  59. Somerville K., Faulkner G., Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet. 1986 Mar 1;1(8479):462–464. doi: 10.1016/s0140-6736(86)92927-2. [DOI] [PubMed] [Google Scholar]
  60. Stamp J., Rhind V., Haslock I. A comparison of nefopam and flurbiprofen in the treatment of osteoarthrosis. Br J Clin Pract. 1989 Jan;43(1):24–26. [PubMed] [Google Scholar]
  61. Steele K., Mills K. A., Gilliland A. E., Irwin W. G., Taggart A. Repeat prescribing of non-steroidal anti-inflammatory drugs excluding aspirin: how careful are we? Br Med J (Clin Res Ed) 1987 Oct 17;295(6604):962–964. doi: 10.1136/bmj.295.6604.962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Summers M. N., Haley W. E., Reveille J. D., Alarcón G. S. Radiographic assessment and psychologic variables as predictors of pain and functional impairment in osteoarthritis of the knee or hip. Arthritis Rheum. 1988 Feb;31(2):204–209. doi: 10.1002/art.1780310208. [DOI] [PubMed] [Google Scholar]
  63. Thonar E. J., Lenz M. E., Klintworth G. K., Caterson B., Pachman L. M., Glickman P., Katz R., Huff J., Kuettner K. E. Quantification of keratan sulfate in blood as a marker of cartilage catabolism. Arthritis Rheum. 1985 Dec;28(12):1367–1376. doi: 10.1002/art.1780281209. [DOI] [PubMed] [Google Scholar]
  64. Troyer H. Experimental models of osteoarthritis: a review. Semin Arthritis Rheum. 1982 Feb;11(3):362–374. doi: 10.1016/0049-0172(82)90057-9. [DOI] [PubMed] [Google Scholar]
  65. Valtonen E. J. Clinical comparison of triamcinolonehexacetonide and betamethasone in the treatment of osteoarthrosis of the knee-joint. Scand J Rheumatol Suppl. 1981;41:1–7. [PubMed] [Google Scholar]
  66. Vignon E., Mathieu P., Couprie N., Cloppet H., Herbage D., Louisot P., Richard M. Effects of tiaprofenic acid on interleukin 1, phospholipase A2 activity, prostaglandins, neutral protease, and collagenase activity in rheumatoid synovial fluid. Semin Arthritis Rheum. 1989 Feb;18(3 Suppl 1):11–15. doi: 10.1016/0049-0172(89)90078-4. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES